Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Immunic is a biopharmaceutical company that develops a pipeline of selective oral immunology therapies.
Perspective Therapeutics focuses on advancing cancer treatments employing radiation, radiopharmaceuticals, and imaging technology.
Dave is a banking app that offers customers banking, financial insights, overdraft protection, and building credit products.
Century Therapeutics is a biotechnology company that develops cell therapies for hematological and solid tumor malignancies.
Beacon Therapeutics is a biotechnology company that develops treatments to preserve and restore vision for rare and prevalent eye diseases.
Athira Pharma is a clinical stage drug development company that specializes in biotechnology and pharmaceutical.
Immunovant is a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune diseases.
Cogent Biosciences is a biotechnology company that develops therapies for solid cancer tumors.
Rapt is focused on the discovery and development of novel small-molecule agents to activate the immune system to eradicate cancer.
Affinia Therapeutics is a biotechnology company developing transformative AAV gene therapies for people with rare and prevalent diseases.
Cidara Therapeutics develops targeted immunotherapies aimed at improving treatment outcomes for patients with serious diseases.
Plexium develops a targeted protein degradation platform to find new therapies for cancer and other diseases.
Equip Health provides a virtual eating disorder treatment program designed to assist families recover from eating disorders at home.
Substack is a subscription-based newsletter publishing platform for independent writers.
Unrivaled Sports manages a diverse portfolio of youth sports properties in Baseball, Softball, Football, and Action Sports.
Arbor Biotechnologies is a biotechnology company specializing in next-generation gene editing therapeutics to treat genetic diseases.
audiochuck is a media company that creates and produces content.
ADARx Pharmaceuticals is a genetic medicine company focusing on the base editing of mRNA transcripts.
Men In Blazers is a soccer-focused media company that covers sports events, leagues, and TV shows.
Aviceda Therapeutics is a late-stage pre-clinical biotech company developing drugs for treating glyco-immune diseases.
CG Oncology is a clinical-stage biopharmaceutical company focused on the development of oncolytic immunotherapies to combat cancer.
The operating system for stablecoins.
Judo Bio is a biotechnology company that develops precision therapeutics targeting specific cell populations to address genetic diseases.
Vicebio is a biopharmaceutical company developing next-generation respiratory virus vaccines using the Molecular Clamp technology.
TCG has invested in 153 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
TCG's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Life Science. The firm invests across 33 different industry categories.
Among tracked funding rounds, Immunovant received $550.0M in a Post-IPO Equity round. TCG's total known invested capital is $1.8B.
TCG's average investment size is $24.7M across its portfolio of 153 companies.
Recent TCG portfolio additions include Immunic Therapeutics, Perspective Therapeutics, Dave, Century Therapeutics, Beacon Therapeutics. These companies were founded in 2020 or later.